The UK government has committed almost £16 million to cutting-edge study in artificial intelligence (AI).
The third round of the AI in Health and Care Awards has awarded funding to nine businesses, accelerating the testing and application of the most cutting-edge AI technologies. The awards were established in 2019 to advance AI technology aimed at assisting patients in managing chronic diseases and enhancing the speed and precision of diagnostics.
The victors include AI systems that can assist the treatment of neurological disorders like dementia, spot cancer, identify women at the greatest risk of preterm delivery, and diagnosis uncommon illnesses. The money will be used to assist the National Health Service in testing, reviewing, and adoption of these companies’ innovations.
One of the companies performs breast cancer screenings using an AI-driven program. By analyzing pictures of tissue samples, the technology enables doctors to identify cancer more rapidly. Another winner in the medical device industry, has been releasing gadgets and treatments to combat more than 30 chronic illnesses, such as diabetes and Parkinsons. A digital health start-up that supports an AI system that analyses electronic health data to identify patients with unidentified uncommon illnesses and suggest the best management strategies has also received an award. A consortium headed by a university has also been awarded that uses an online medical tool to identify pregnant women who are most at risk of giving birth early or experiencing problems that could result in birth defects.
One of the top 5 objectives of the UK government is reducing wait times for the National Health Service, which is supported by record spending of up to £14.1 billion for health and social care over the next two years.
The government is confident that technological advancements, such as those in robotics and artificial intelligence, will give people more control and aid in the fight against some of the largest healthcare challenges, such as genetic illnesses and cancer. Innovations of this nature can expedite diagnostics and therapies while freeing up staff time.
Source: Gov.uk
